These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9696305)
21. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Buzzi MG; Moskowitz MA Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351 [TBL] [Abstract][Full Text] [Related]
22. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Buzzi MG; Moskowitz MA Br J Pharmacol; 1990 Jan; 99(1):202-6. PubMed ID: 2158835 [TBL] [Abstract][Full Text] [Related]
23. CP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater. Matsubara T; Moskowitz MA; Byun B Br J Pharmacol; 1991 Sep; 104(1):3-4. PubMed ID: 1664765 [TBL] [Abstract][Full Text] [Related]
24. Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Cutrer FM; Schoenfeld D; Limmroth V; Panahian N; Moskowitz MA Br J Pharmacol; 1995 Mar; 114(5):987-92. PubMed ID: 7780655 [TBL] [Abstract][Full Text] [Related]
25. Effect of hyperoxia on neurogenic plasma protein extravasation in the rat dura mater. Schuh-Hofer S; Siekmann W; Offenhauser N; Reuter U; Arnold G Headache; 2006; 46(10):1545-51. PubMed ID: 17115987 [TBL] [Abstract][Full Text] [Related]
26. 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Buzzi MG; Dimitriadou V; Theoharides TC; Moskowitz MA Brain Res; 1992 Jun; 583(1-2):137-49. PubMed ID: 1324091 [TBL] [Abstract][Full Text] [Related]
28. Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation. Johnson KW; Nelson DL; Dieckman DK; Wainscott DB; Lucaites VL; Audia JE; Owton WM; Phebus LA Cephalalgia; 2003 Mar; 23(2):117-23. PubMed ID: 12603368 [TBL] [Abstract][Full Text] [Related]
29. Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Ebersberger A; Averbeck B; Messlinger K; Reeh PW Neuroscience; 1999 Mar; 89(3):901-7. PubMed ID: 10199623 [TBL] [Abstract][Full Text] [Related]
30. Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis. Cutrer FM; Yu XJ; Ayata G; Moskowitz MA; Waeber C Neuropharmacology; 1999 Jul; 38(7):1043-53. PubMed ID: 10428423 [TBL] [Abstract][Full Text] [Related]
31. Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches. Lacković Z; Filipović B; Matak I; Helyes Z Br J Pharmacol; 2016 Jan; 173(2):279-91. PubMed ID: 26493010 [TBL] [Abstract][Full Text] [Related]
32. Capsaicin stimulation of the cochlea and electric stimulation of the trigeminal ganglion mediate vascular permeability in cochlear and vertebro-basilar arteries: a potential cause of inner ear dysfunction in headache. Vass Z; Steyger PS; Hordichok AJ; Trune DR; Jancsó G; Nuttall AL Neuroscience; 2001; 103(1):189-201. PubMed ID: 11311800 [TBL] [Abstract][Full Text] [Related]
33. Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy. Filipović B; Matak I; Bach-Rojecky L; Lacković Z PLoS One; 2012; 7(1):e29803. PubMed ID: 22238656 [TBL] [Abstract][Full Text] [Related]
34. Simultaneous measurement of plasma protein extravasation and carotid vascular resistance in the rat. Spokes RA; Middlefell VC Eur J Pharmacol; 1995 Jul; 281(1):75-9. PubMed ID: 8566120 [TBL] [Abstract][Full Text] [Related]
36. Effect of antimigraine drugs on dural blood flows and resistances and the responses to trigeminal stimulation. Lambert G; Michalicek J Eur J Pharmacol; 1996 Sep; 311(2-3):141-51. PubMed ID: 8891594 [TBL] [Abstract][Full Text] [Related]
37. The mode of action of sumatriptan is vascular? A debate. Humphrey PP; Goadsby PJ Cephalalgia; 1994 Dec; 14(6):401-10; discussion 393. PubMed ID: 7697699 [TBL] [Abstract][Full Text] [Related]
38. The trigemino-vascular system and migraine. Buzzi MG; Moskowitz MA Pathol Biol (Paris); 1992 Apr; 40(4):313-7. PubMed ID: 1379707 [TBL] [Abstract][Full Text] [Related]
39. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Buzzi MG; Carter WB; Shimizu T; Heath H; Moskowitz MA Neuropharmacology; 1991 Nov; 30(11):1193-200. PubMed ID: 1663596 [TBL] [Abstract][Full Text] [Related]
40. Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater. Buzzi MG; Sakas DE; Moskowitz MA Eur J Pharmacol; 1989 Jun; 165(2-3):251-8. PubMed ID: 2776831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]